Geode Capital Management, LLC Sangamo Therapeutics, Inc Call Options Transaction History
Geode Capital Management, LLC
- $1.39 Trillion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SGMO
# of Institutions
126Shares Held
50.6MCall Options Held
1.13MPut Options Held
820K-
Vanguard Group Inc Valley Forge, PA9.37MShares$4.87 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT8.08MShares$4.2 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.84MShares$3.56 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$2.45 Million0.0% of portfolio
-
Gsa Capital Partners LLP London, X02.25MShares$1.17 Million0.09% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $81.4M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...